Longevity Medicine Beyond ‘Failure-Based’ Healthcare with Dr Peter Scriven

In this episode of Beyond Longevity, Daphne speaks with Dr Peter Scriven, founder and medical director of LONGEVITY. Health, about shifting healthcare from diagnosing disease after a threshold is crossed to tracking health as a trajectory and intervening earlier. Dr Peter argues the NHS largely practises ‘failure-based medicine’, where ‘normal’ lab ranges are statistical constructs that can miss suboptimal trends, and he advocates longitudinal ‘human telemetry’ using detailed diagnostics with clear clinical rationale, ownership, and sensible testing intervals to avoid over-testing. He outlines a core panel of 50–80 blood biomarkers plus targeted tests based on age, sex, symptoms, and goals, discusses costs (from £400–£500 to the low thousands, rising with imaging), and stresses foundational behaviours, movement, nutrition, sleep, and purpose, as the most powerful interventions. He shares how his father’s missed cardiovascular risk and inadequate lipid testing influenced his approach, warns about unregulated ‘Wild West’ longevity claims (including peptides), suggests due diligence via GMC and CQC checks, and recommends minimal priorities on a budget: proper cardiovascular risk assessment, omega-3/6 ratios, and GlycanAge. Dr Peter Scriven FRCGP is a doctor, scientist and co-founder of LONGEVITY. His 26-year career has spanned surgery, proteomic research, general practice and senior medical leadership. He is focused on building a medically led, clinically governed model of longevity medicine that sits between conventional healthcare, which often intervenes too late, and hype-led commerce that moves faster than the evidence and too often disregards regulation and experience. Dr Peter Scriven FRCGP is a doctor, scientist and co-founder of LONGEVITY. His 26-year career has spanned surgery, proteomic research, general practice and senior medical leadership. He is focused on building a medically led, clinically governed model of longevity medicine that sits between conventional healthcare, which often intervenes too late, and hype-led commerce that moves faster than the evidence and too often disregards regulation and experience. https://longevityclinics.life/ https://www.linkedin.com/in/drpscriven/ 00:00 Why Prevention Matters 03:12 Failure-Based Medicine 04:34 Human Telemetry Monitoring 06:28 Testing Without Overtesting 09:53 Core vs Targeted Panels 13:13 Cost and ROI of Diagnostics 17:54 Healthspan Intervention Pyramid 20:53 Normal Ranges vs Trajectories 24:36 Missed Risks Real Stories 28:46 Breaking Medical Silos 33:49 Renaissance Medic Mindset 36:05 Training Beyond Silos 36:49 Regulating Longevity Medicine 37:43 Patients or Permanent Clients 41:01 Too Much Testing Ethics 44:08 Peptides and Amateur Hype 45:42 How to Vet a Clinic 49:01 Budget Biomarkers That Matter 52:13 Foundations and Wearables 55:19 Future of Cellular Medicine 58:30 Long-Term Clinic Journey 01:00:00 Rapid Fire and Wrap Up